161 related articles for article (PubMed ID: 30659267)
1. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
Köhler M; Ehrenfeld S; Halbach S; Lauinger M; Burk U; Reischmann N; Cheng S; Spohr C; Uhl FM; Köhler N; Ringwald K; Braun S; Peters C; Zeiser R; Reinheckel T; Brummer T
Oncogene; 2019 Feb; 38(8):1324-1339. PubMed ID: 30659267
[TBL] [Abstract][Full Text] [Related]
2. Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis.
Schreiber C; Gruber A; Roßwag S; Saraswati S; Harkins S; Thiele W; Foroushani ZH; Munding N; Schmaus A; Rothley M; Dimmler A; Tanaka M; Garvalov BK; Sleeman JP
Cancer Lett; 2022 May; 533():215600. PubMed ID: 35181478
[TBL] [Abstract][Full Text] [Related]
3. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
[TBL] [Abstract][Full Text] [Related]
5. Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.
Terrell EM; Durrant DE; Ritt DA; Sealover NE; Sheffels E; Spencer-Smith R; Esposito D; Zhou Y; Hancock JF; Kortum RL; Morrison DK
Mol Cell; 2019 Dec; 76(6):872-884.e5. PubMed ID: 31606273
[TBL] [Abstract][Full Text] [Related]
6. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
7. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract][Full Text] [Related]
8. BRAF
Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
[TBL] [Abstract][Full Text] [Related]
9. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
10. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.
Heß L; Aliar K; Grünwald BT; Griffin R; Lozan A; Knöller M; Khokha R; Brummer T; Reinheckel T
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167133. PubMed ID: 38531482
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Mahmood N; Arakelian A; Szyf M; Rabbani SA
Exp Mol Med; 2024 Apr; 56(4):959-974. PubMed ID: 38556549
[TBL] [Abstract][Full Text] [Related]
13. A positive TGF-β/miR-9 regulatory loop promotes the expansion and activity of tumour-initiating cells in breast cancer.
Liu Y; Chen Y; Zhao Q; Xie T; Xiang C; Guo Q; Zhang W; Zhou Y; Yuan Y; Zhang Y; Xi T; Li X; Zheng L
Br J Pharmacol; 2023 Sep; 180(17):2280-2297. PubMed ID: 37060166
[TBL] [Abstract][Full Text] [Related]
14. PyMT-1099, a versatile murine cell model for EMT in breast cancer.
Saxena M; Kalathur RKR; Neutzner M; Christofori G
Sci Rep; 2018 Aug; 8(1):12123. PubMed ID: 30108334
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of the COX2/PGE
Yoshitake R; Saeki K; Eto S; Shinada M; Nakano R; Sugiya H; Endo Y; Fujita N; Nishimura R; Nakagawa T
Sci Rep; 2020 May; 10(1):7826. PubMed ID: 32385388
[TBL] [Abstract][Full Text] [Related]
16. Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
Velazquez FN; Zhang L; Viscardi V; Trocchia C; Hannun YA; Obeid LM; Snider AJ
PLoS One; 2021; 16(5):e0252311. PubMed ID: 34043703
[TBL] [Abstract][Full Text] [Related]
17. RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.
Tolg C; Milojevic M; Qi FW; Pavanel HA; Locke MEO; Ma J; Price M; Nelson AC; McCarthy JB; Hill KA; Turley EA
Breast Cancer Res; 2023 Jun; 25(1):74. PubMed ID: 37349798
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T Cells Control the Switch From
Martinez LM; Robila V; Clark NM; Du W; Idowu MO; Rutkowski MR; Bos PD
Front Immunol; 2019; 10():1942. PubMed ID: 31555258
[TBL] [Abstract][Full Text] [Related]
19. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract][Full Text] [Related]
20. Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes.
Leung KK; Wilson GM; Kirkemo LL; Riley NM; Coon JJ; Wells JA
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7764-7775. PubMed ID: 32205440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]